Personal information

No personal information available

Activities

Works (12)

Distinct lung cell signatures define the temporal evolution of diffuse alveolar damage in fatal COVID-19

eBioMedicine
2024-01 | Journal article
Contributors: Luke Milross; Bethany Hunter; David McDonald; George Merces; Amanda Thomson; Catharien M.U. Hilkens; John Wills; Paul Rees; Kasim Jiwa; Nigel Cooper et al.
Source: check_circle
Crossref

Integrated histopathology, spatial and single cell transcriptomics resolve cellular drivers of early and late alveolar damage in COVID-19

2023-12-20 | Preprint
Contributors: Jimmy Tsz Hang Lee; Sam N. Barnett; Kenny Roberts; Helen Ashwin; Luke Milross; Jae-Won Cho; Alik Huseynov; Benjamin Woodhams; Alexander Aivazidis; Tong Li et al.
Source: check_circle
Crossref

Distinct lung cell signatures define the temporal evolution of diffuse alveolar damage in fatal COVID-19

2023-05-07 | Preprint
Contributors: Luke Milross; Bethany Hunter; David McDonald; George Merces; Amanda Thompson; Catharien M.U. Hilkens; John Wills; Paul Rees; Kasim Jiwa; Nigel Cooper et al.
Source: check_circle
Crossref

OPTIMAL: An OPTimised Imaging Mass cytometry AnaLysis framework for Segmentation and Data Exploration

2023-02-21 | Preprint
Contributors: Bethany Hunter; Ioana Nicorescu; Emma Foster; David McDonald; Gillian Hulme; Fuller Andrew; Amanda Thomson; Catharien M.U. Hilkens; Joaquim Majo; Luke Milross et al.
Source: check_circle
Crossref

Down-regulation ofMALAT1is a hallmark of tissue and peripheral proliferative T cells in COVID-19

2023-01-07 | Preprint
Contributors: Shoumit Dey; Helen Ashwin; Luke Milross; Bethany Hunter; Joaquim Majo; Andrew J Filby; Andrew J Fisher; Paul M. Kaye; Dimitris Lagos
Source: check_circle
Crossref

Identification of a protein expression signature distinguishing early from organising diffuse alveolar damage in COVID-19 patients

2022-12-13 | Preprint
Contributors: Helen Ashwin; Luke Milross; Julie Wilson; Joaquim Majo; Jimmy Tsz Hang Lee; Grant Calder; Bethany Hunter; Sally James; Dimitris Lagos; Nathalie Signoret et al.
Source: check_circle
Crossref

The trajectory of COVID-19 cardiopulmonary disease: insights from an autopsy study of community-based, pre-hospital deaths

ERJ Open Research
2022-10 | Journal article
Contributors: Luke Milross; Joaquim Majo; Julian Pulle; Sam Hoggard; Nigel Cooper; Bethany Hunter; Christopher J.A. Duncan; Andrew Filby; Andrew J. Fisher
Source: check_circle
Crossref

Ex Vivo Lung Perfusion: A Platform for Donor Lung Assessment, Treatment and Recovery

Transplantology
2021-09-27 | Journal article
Contributors: Luke Milross; Chelsea Griffiths; Andrew J. Fisher
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Perceptions held by healthcare professionals concerning organ donation after circulatory death in an Australian intensive care unit without a local thoracic transplant service: A descriptive exploratory study

Australian Critical Care
2021-07 | Journal article
Part of ISSN: 1036-7314
Source: Self-asserted source
Luke Milross

Not Quite a Mono Spot Diagnosis. Splenic Infarction Complicating Infectious Mononucleosis

The American Journal of Medicine
2021-05 | Journal article
Contributors: Jacqueline V. Patruno; Luke Milross; Muhammad M. Javaid
Source: check_circle
Crossref

Exploring staff perceptions of organ donation after circulatory death

Australian Critical Care
2020-03 | Journal article
Part of ISSN: 1036-7314
Source: Self-asserted source
Luke Milross

Lung autoantibodies: Ready for prime time?

The Journal of Heart and Lung Transplantation
2018-02 | Journal article
Part of ISSN: 1053-2498
Source: Self-asserted source
Luke Milross